B Capital
VC Fund
Manhattan Beach, United States
B Capital is a VC fund in Manhattan Beach focused on Software and Artificial Intelligence. B Capital Group supports entrepreneurs building technology companies with a focus on start-ups aiming to scale internationally. The company partners with Boston Consulting Group and its incubation arm, BCG Digital Ventures, to help connect start-ups with corporations across various industries. B Capital Group maintains a portfolio of B2B and B2B2Ccompanies operating in multiple sectors and regions. It provides support in areas such as business development, capital raising, and organizational growth during key stages of company expansion.
- Total investments:
- 348
- Last investment:
- Lead investor:
- 47%
- Fund size:
- $500M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries B Capital invests in
Stages B Capital invests in
Countries B Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 24 contacts → | |||
Round size
- Series A
- $7.3M–$85M
- Series B
- $14M–$125M
- Series C
- $30M–$158M
Investment Focus
Industry
- Software 40 (11%)
- Artificial Intelligence 36 (10%)
- Health Care 35 (10%)
- SaaS 27 (8%)
- Information Technology 26 (7%)
Stage
- Series B 53 (15%)
- Series A 42 (12%)
- Series C 36 (10%)
- Seed 30 (9%)
- Series D 22 (6%)
Country
- United States 109 (31%)
- India 16 (5%)
- Singapore 10 (3%)
- Indonesia 7 (2%)
- China 5 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allen Duan
General Partner
|
General Partner | Total investments: 2 | Find email | |
Daisy Cai
General Partner
|
General Partner | Total investments: 4 | Find email | |
Kabir Narang
Founding General Partner
|
Founding General Partner | Total investments: 47 | Find email | |
Karen Page
General Partner
|
General Partner | Total investments: 36 | Find email | |
Kelly Qiao
Senior Principal
|
Senior Principal | Total investments: 0 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NeuShen Therapeutics
|
NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders. | $80M / Series B / Sep 03, 2026 | |
ChipAgents
|
Alpha Design AI is reinventing semiconductor design and verification through advanced AI agent techniques. Alpha Design AI is pioneering an AI-native approach to Electronic Design Automation (EDA), transforming how chips are designed and verified. Our flagship product, ChipAgents, aims to boost RTL design and verification productivity by 10x,driving innovation across industries with smarter, more efficient chip design. | $60M / Series A / Jul 29, 2026 | |
Flourish Health
|
Flourish Health is a medical center that treats high-acuity mental health conditions including PTSD, depressive, and serious mood disorders. | $26M / Series A / Jul 27, 2026 | |
Kaon
|
FlowGPT is a LLM prompt platform that allows anyone to explore, use, and share prompts across different LLMs. On FlowGPT, users can find high-quality prompts and their potential use cases. It is also an open-source community, a "Github" for prompt creators to collaborate, iterate, and manage their prompts. | $60M / Series B / Jul 08, 2026 | |
|
Grace Investment Machine
|
Grace Investment Machine is a next-generation, self-evolving intelligent agent investment platform designed to continuously learn from market dynamics, adapt its strategies in real time, and deliver data-driven insights that help investors optimize portfolio performance, manage risk effectively, and make smarter, faster investment decisions in anever-changing financial landscape. | Series A / Jun 25, 2026 | |
Seltz
|
Web Search Engine | $12.5M / Seed / Jun 24, 2026 | |
Cadence Solutions
|
Cadence is a healthcare technology company that provides remote patient care and chronic disease management services for health systems and providers. It operates a clinical AI-driven platform that monitors patients at home and supports ongoing treatment for conditions such as hypertension, diabetes, and heart failure through connected devices,data tracking, and clinician-led care workflows. The company’s model centers on continuous monitoring of patient vitals like blood pressure, weight, symptoms, and medication adherence, with data flowing into a clinical intelligence system that flags risks and supports early intervention. | $100M / Series C / Jun 23, 2026 | |
SolarSquare Energy
|
SolarSquare provides rooftop solar solutions for residential homes, housing societies, and commercial establishments, offering services that include system design, installation, maintenance, and financing support. The company manages the solar adoption process from site assessment and customized system design to installation, subsidy assistance,and ongoing system monitoring. It also offers a mobile application that allows customers to track electricity generation and system performance in real time. SolarSquare focuses on improving access to solar energy through standardized processes, engineering support, and maintenance services aimed at ensuring long-term system operation. The company serves customers across multiple cities in India and works to support the adoption of distributed solar power through rooftop installations. | Series D / Jun 12, 2026 | |
|
SolarSquare Energy
|
SolarSquare provides rooftop solar solutions for residential homes, housing societies, and commercial establishments, offering services that include system design, installation, maintenance, and financing support. The company manages the solar adoption process from site assessment and customized system design to installation, subsidy assistance,and ongoing system monitoring. It also offers a mobile application that allows customers to track electricity generation and system performance in real time. SolarSquare focuses on improving access to solar energy through standardized processes, engineering support, and maintenance services aimed at ensuring long-term system operation. The company serves customers across multiple cities in India and works to support the adoption of distributed solar power through rooftop installations. | $53M / Series C / Jun 12, 2026 | |
NRx Pharmaceuticals
|
NRx Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics for the treatment of central nervous system disorders and pulmonary diseases. It addresses life-threatening diseases that often go untreated by researching, developing, and scaling solutions to help people who most desperately need them.The company hasannounced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure, and is also developing NRX-100/101 which is the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.In July 2021, the Government of Israel awarded NRx the exclusive worldwide right to develop and market the BriLifeR COVID vaccine developed by the Israel Institute for Biological Research. | $22.3M / Post-IPO Equity / Jun 03, 2026 | |
| See all 348 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does B Capital invest in?
B Capital invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series B and Series A stage. Most of the 348 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is B Capital's check size?
B Capital typically joins rounds of $7.3M–$85M at Series A, $14M–$125M at Series B and $30M–$158M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds B Capital participates in.
How do I contact B Capital?
Public channels for B Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at B Capital?
The team at B Capital includes Allen Duan (General Partner), Daisy Cai (General Partner) and Kabir Narang (Founding General Partner), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
